Already a member? Sign in
Tipranavir is a protease inhibitor that is used in the treatment of HIV-1 infections in combination with ritonavir and other antiretroviral agents; limited to highly treatment-experienced or multiprotease inhibitor-resistant patients.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| HIV (Human Immunodeficiency Virus) | 1 | 0 | |||||
| None | 1 | 0 |
See all 2 patients currently taking Tipranavir
Mouse over the table for more information
| 1,000 mg daily | ||
|---|---|---|
2
|
||
See more information, including instructions, precautions, side effects, and interactions.
Report created on February 11, 2012.